Efficacy and safety of bevacizumab combined with temozolomide in the treatment of recurrent malignant gliomas and its influence on serum tumor markers

CONCLUSIONS: BZ+TMZ is effective in treating recurrent malignant gliomas, which can improve the QoL and survival of patients.PMID:35035729 | PMC:PMC8748084

Source: American Journal of Translational Research - January 17, 2022 Category: Research Authors: Jun Lei Zhi Zhou Source Type: research